Unknown

Dataset Information

0

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma.

ABSTRACT:

SUBMITTER: Sanfilippo F 

PROVIDER: S-EPMC7874424 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Functional Antibodies in COVID-19 Convalescent Plasma.
| S-EPMC7987034 | biostudies-literature
Unknown How Safe Is COVID-19 Convalescent Plasma?
| S-EPMC8226036 | biostudies-literature
Unknown Convalescent plasma in patients hospitalised with COVID-19.
| S-EPMC8121524 | biostudies-literature
Unknown Heterogeneity in COVID-19 Convalescent Plasma Clinical Trials.
| S-EPMC8426852 | biostudies-literature
Unknown COVID-19 versus HIT hypercoagulability.
| S-EPMC7416717 | biostudies-literature
Unknown Convalescent plasma in Covid-19: Possible mechanisms of action.
| S-EPMC7198427 | biostudies-literature
Unknown COVID-19 convalescent plasma therapy: hit fast, hit hard!
| S-EPMC8251446 | biostudies-literature
Unknown COVID-19 convalescent plasma; time for "goal directed therapy"?
| S-EPMC8250757 | biostudies-literature
Unknown Current Perspectives of convalescent plasma therapy in COVID-19.
| S-EPMC7927533 | biostudies-literature
Unknown Target specific serologic analysis of COVID-19 convalescent plasma.
| S-EPMC8081213 | biostudies-literature